chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; This initial spontaneous report was received from a lawyer and a patient of unknown age and gender regarding a case in litigation on 17-JUN-2020. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On or about 23-JUN-2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, lot #, expiration date, route of administration, anatomical location not provided) prescribed and/or administered by a pharmacist for the long-term prevention of shingles and/or zoster-related conditions. On an unspecified date, subsequently to patient's zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a physician at a medical center for shingles. As a direct and proximate result of use of zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries; including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. At the reporting time, the outcome of herpes zoster was considered as not recovered. The reporters considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).
Patient was given 1st dose of HPV then approximately 5 minutes later while patient was standing in exam room she started to faint. Mother assisted patient to a laying position on the couch in the exam room. Patient was examined by Dr. and given an ice pack and a glass of water. Patient stayed laying for 15 minutes then sat up for 15 minutes prior to leaving clinic to ensure safety.
hives- like breaking out on fore head a lot of swelling in face numbness glands swollen under tongue
Started with itchy mouth and itchy soft palate. Progressed to itchy throat. Gave 50mg of Benedryl with no relief, progressed to difficulty breathing, and increased throat itching. Gave EPI pen and sent to ER
develop a bulge in the vein that is starting to get bigger every day.; painful; This spontaneous case was reported by a patient and describes the occurrence of VARICOSE VEIN (develop a bulge in the vein that is starting to get bigger every day.) and PAIN (painful) in a 26-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 072E22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. In October 2022, the patient experienced VARICOSE VEIN (develop a bulge in the vein that is starting to get bigger every day.) and PAIN (painful). At the time of the report, VARICOSE VEIN (develop a bulge in the vein that is starting to get bigger every day.) and PAIN (painful) outcome was unknown.            No concomitant medications was reported.  Reported that patient received a dose of the bivalent vaccine and experienced side effects.   Patient received 4 doses of the Moderna COVID-19 vaccines by intramuscular injection on 05-APR-2021 (lot number 032B21A, expiration date unknown), 08-MAY-2021 (lot number 033C21A, expiration date unknown), 23-NOV-2021 (lot number 939909, expiration date unknown), and 15-OCT-2022 (bivalent, lot number 072E22A, expiration date unknown).  Patient had not taken any medications or treatments. Patient had an appointment to speak to his HCP next week.   This case was linked to MOD-2022-662427 (Patient Link).
lightheaded, swollen face and a face nodule Narrative: employee states: She felt lightheaded during 2 days following vaccination. She also experienced a swollen face approx 8 hours after injection with a hard nodule subcutaneously on the left face
vomiting; diarrhea; sweats; chills; This is a spontaneous report from a non-contactable consumer. This 39-year-old non-pregnant female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via an unspecified route of administration on 20Feb2021 at 10:00 hours in left arm (at 39-year-old), at single dose for COVID-19 immunization. The patient's medical history was reported as none. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. The patient did not have covid prior vaccination and was not tested for covid post vaccination. She had no allergies. About 18 hours after administration on 21Feb2021 at 06:00 AM the patient experienced intense vomiting and diarrhea, along with sweats and chills. These symptoms continued for about 5 hours. The patient received treatment with nausea medication. The patient was recovering.  Information about lot/Batch number has been requested.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Fever, vomiting, diarrhea, joint pain began within 8 hours of Tdap administration.
Aching legs; Gradually getting worse; Her memory is affected; Muscle aches and pains; Felt out of sorts; Arm was sore; This is a spontaneous report from a contactable other hcp (nurse). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in arm right on 18Jan2021 at 09:00 (Lot Number: EL3247, Expiration Date: Apr2021) as single dose for COVID-19 immunization. The patient's medical history included spinal fusion surgery from 2019 to an unknown date. The patient previously received 1st Shingrix injection and experienced her arm turned really red and swelled up (so her doctor told her not to take the 2nd injection). There were no concomitant medications. On 19Jan2021, the patient experienced arm was sore. On 21Jan2021, the patient felt out of sorts. On 22Jan2021, the patient experienced muscle aches and pains. She is not sure if the muscle aches are due to her just getting old or from the vaccine. The muscle aches are especially in her legs. On an unspecified date, the patient experienced aching legs, gradually getting worse and her memory is affected. She is gradually getting worse, but doesn't know if it's the weather, or is it a possibility that it's the vaccine. The patient's memory is affected, then clarified that it has nothing to do with the vaccine, she is just getting old. She asked if people have reported muscle aches and pains for weeks after. She is due to have the second injection on 08Feb2021. No family medical history relevant to events. The events did not result in emergency room visit or physician office visit. The outcome of the muscle aches and pains was not recovered and was unknown for the rest of the events.   Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a licensed practical nurse refers to an unknown number patient of unknown age and gender. Since 02-JAN-2015, an unknown number of doses of PROQUAD (Merck), (exact dose, anatomical location, lot # and expiration date were not reported), which underwent supported temperature excursion, have been subcutaneously administered to an unknown number of patients. No adverse effects reported. This is the of several reports from the same reporter source. Additional information has been requested.
Menstrual Cycle that lasted for 29 days, irregular, heavy, many clots... abnormal cycles ever since. Bloodwork normal, biopsy, ultrasound completed.
heart palpitations, chest pain, tachycardia, HTN and dizziness. lasted for several hours and has had intermittent episodes daily since receiving the vaccine.
Delayed skin reaction. large pruritic erythematous patch surrounding vaccine site on day #9 after first vaccination. seen on Day #10.
The patients husband walked her up to the front clerical area saying ?I think my wife is having a reaction.? The patient was immediately sent to an exam room to be checked by a nurse. Initial b/p was 210/125 pulse 108, 2nd b/p 208/110 pulse 112, 3rd b/p 161/105 pulse 108. Husband and patient both said they thought she was having a panic disorder and said that ?this happened a lot.? Patient said ?I left my medication I normal take for panic disorder at home and I live an hour away from here.? Pt asked if we keep medication for panic disorder. Pt was told that the facility did not keep medications like that in the building. Patient and husband agreed to let the facility staff call 911 due to elevated b/p. Pt requested that the nurses to not tell her what her blood pressure was, stating ?it makes me too nervous and feel worse.? When EMS arrived b/p was lower 160/90. Repeat b/p within 4 minutes 160/87, pulse 75. Patient asked EMT?s if they kept medication for panic disorder on the truck. Patient was told that if she was to get any medication from them, she would have to be taken to the hospital. Patient declined the transport to the hospital, stating ?I feel much better and I think I will just go home to get my medication.? Husband requested to take his wife home to get her medication instead of going to the hospital. Patient was released home with husband.
This is a spontaneous report from a Pfizer-sponsored program "SNOW Patient Testimonial Recruitment", from a contactable consumer reporting for herself. A female patient of an unspecified age and ethnicity started to receive PREVNAR 13, via an unspecified route of administration, on 16Oct2017, at single dose, for immunisation. Relevant medical history and concomitant medications were not reported. The patient experienced very tired, the injection site was swollen and had a blister all on an unspecified date with outcome of unknown.
chills; muscle pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MYALGIA (muscle pain) and HEADACHE (headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006Y21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced CHILLS (chills), MYALGIA (muscle pain) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), MYALGIA (muscle pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided
I had the Moderna COVID vaccine on Jan 28.   That night my throat was swollen and I had a hard time swallowing.  I was fine next day. Saturday I had a rash on both arms that continues.
Cough and stuffy nose lasting more than two weeks so far; fever of 102.4, severe headache
Started to feel body aches, slight headache about 4am on 4/8. Started taking 2 extra strength tylenol every 8 hours through following morning. Symptoms were up and down for 24 hours. No fever but felt flu-like and they were gone on 4/9
migraine; body aches; fever; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of MIGRAINE (migraine), MYALGIA (body aches) and PYREXIA (fever) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     The patient's past medical history included Migraine.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced MIGRAINE (migraine), MYALGIA (body aches) and PYREXIA (fever). At the time of the report, MIGRAINE (migraine), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up received, NNI
This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue after receiving Moderna COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue after receiving Moderna COVID-19 vaccine). At the time of the report, FATIGUE (Fatigue after receiving Moderna COVID-19 vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
that it has been almost 7 weeks from the first dose; but I was sick on the day I was supposed to get the second; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (that it has been almost 7 weeks from the first dose) and ILLNESS (but I was sick on the day I was supposed to get the second) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (that it has been almost 7 weeks from the first dose) and ILLNESS (but I was sick on the day I was supposed to get the second). At the time of the report, PRODUCT DOSE OMISSION ISSUE (that it has been almost 7 weeks from the first dose) and ILLNESS (but I was sick on the day I was supposed to get the second) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information received on 25-MAY-2021, contains no new information.
[COVID-19 Vaccine] treatment under Emergency Use Authorization(EUA): 1 mL 25G x 1" *(REF 10161, LOTG200926) used for the Pfizer BioNTech Covid-19 Vaccine for IM injection. While drawing up the first dose of the COVID vaccine in a reconstituted vial, a Pharmacist noticed a green particulate in the syringe. Uncertain of the origin of the particulate, the subsequent dose was not used. Instead, a filter needle with a 1 mL BD Leur Lock syringe was used to draw up remaining doses, then the filter needle was replaced with a 25G x 1" needle. None of the COVID-19 vaccine was affected, and the particulate did not appear to have originated from the stopper of the vaccine vial, as the stopper was grey in color, not green like the particulate found in the syringe. All previously drawn-up doses were inspected and none of the syringes contained particulates.
Starting 01/10/2022, I developed a rash across my chest and upper back, and a sore throat. On 01/11/2022, I went to work and I felt a little off but not enough to be off. I left in the middle of the day not feeling well. I had a fever spiking at around 102, a headache and body aches, joint pain and sore throat which worsened. The cough started either that night or the next day (01/12/2022). For about 3-4 days I would experience the same symptoms but nonstop. I tested positive on 01/12/2022. My temp started to subside around 01/15/2022 and it would remain at about 99F-100F for about a week. I still felt fatigued, body aches, cough, sore throat and runny nose until about 01/28 or 01/29. Then, I returned to work on 01/31/2022. It wasn't until then I noticed the "brain fog" which lasted for about a month. The last week of January my taste seemed to change and things started tasting funny/metallic. To this day, my taste has not returned and I have lost about 40 lbs due to being unable to tolerate most foods: dairy tastes sour/spolied, meat tastes rancid/bad, everything else has a chemical/dirt taste (breads and vegetables) and I am unable to tolerate sweets (make me nauseous). Also, around the 2nd week of being sick I developed extreme coldness in my hands and feet which would require extremely hot temperatures to rewarm them. To this day, I still get episodes of tingling coldness in my hands and feet but more intermittent (about 1x weekly now). During this episode, someone gave me a pulse ox to monitor my oxygen levels and the lowest they ever went were about 90% and, at that time, I was having shortness of breath and feeling very fatigued.
No adverse effects were reported in the patient; The patient recieved her first dose of ROTATEQ at age of 14 weeks; This spontaneous report was received from a medical assistant regarding a 14 weeks female patient. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies, and concomitant therapies were not reported.   On 15-NOV-2019, the patient received her first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), 1 dose, lot number S004398, expiration date 31-OCT-2020 (strength and route of administration was not provided) at age of 14 weeks (product administered to patient of inappropriate age). No adverse effects were reported.
Consistent and uncontrolled urticaria, only manageable with Prednisone Uncomfort in throat
Felt achy; High temperature; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Felt achy) and PYREXIA (High temperature) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen, Citrate free. On an unknown date, the patient experienced PAIN (Felt achy) and PYREXIA (High temperature). At the time of the report, PAIN (Felt achy) and PYREXIA (High temperature) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: High.         The concomitant medication was not reported by reporter. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The treatment medication was not reported by reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
headache; Stomachache; Digestive problems; This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced headache, stomach pain and digestion impaired. On an unknown date, the outcome of the headache, stomach pain and digestion impaired were unknown.   It was unknown if the reporter considered the headache, stomach pain and digestion impaired to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and developed adverse reactions headache, stomachache, digestive problems.
High fever 103.4, chills, nausea, ringing in my ears.  I took Tylenol at midnight.  It?s 7 am now and I?m feeling a little better.
This spontaneous report was received from a 69 years old female consumer refers to herself with severe arthritis and narcolepsy. The patient was allergic to high doses of REMICADE, and some insulins. On 23-JUL-2013 the patient was vaccinated with a single standard dose of ZOSTAVAX (lot#batch# unspecified), unspecified route and location. No concomitant therapies included. The patient explained that within 27 hours of receiving ZOSTAVAX on approximately 24-JUL-2013, she developed muscle seizing in her arms, below her shoulders, and in her jaw. The pain occurred in her muscle and not in her joints. The patient was hospitalized for 2 days due to the event. The patient explained that the shot was mildly painful when received. She also stated that she had developed a small knot at the injection site that spawned the muscle pain when depressed; the effect had lessened over time but still sore to the touch. The pain was felt throughout her arm, shoulder, and jaw muscle upon touching the knot at injection to the point that her jaw seized on her left side during the night that clenched so hard that it left a bruise. The patient had sought medical attention via hospitalized. Treatment was given by morphine for events. At the time of report, the outcome of the events were recovering. Additional information has been requested.
Clear or white areas on fingertips and between fingers, some raised others flat, all fluid filled.  Areas open on their own, drain clear fluid then dry up. Areas are tender to touch. Denies itching.  Started occuring 1 week after administration of vaccine.  As of 9/4/09, continues to have a few areas on each hand that are tender to touch.
Previously received Tdap in 7/27/10 duplicate Tdap received on 9/29/14.
Menstrual spotting; Heavy period; Painful period; Nauseous; Vomited; This is a spontaneous report from a non-contactable consumer, the patient. A 30 years old non pregnant female patient received the first dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: unknown) via an unspecified route of administration on the left arm on 15Mar2021 at 14:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received SSRI (as reported) for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested positive for COVID-19. On 17Mar2021 at 14:00, the patient experienced menstrual spotting after her shot, and patient period was 3 days early. The patient period had been very heavy and very painful and patient had never experienced a period like that before. The patient had felt nauseous and had vomited. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events menstrual spotting, early period, heavy period, painful period, nausea and vomiting was unknown.    No follow-up attempts are possible; information about lot number cannot be obtained.
C/O extreme chills and body aches that kept her in bed for 26 hours following mandatory flu vaccine. Denies respiratory problems, no swelling of lips or throat, fever, or pain at injection site.